Business Standard

Supriya Lifescience Share Price

Know More
NSEBSE

366.70-0.85 (-0.23%)

03:50 PM,18th Apr 2024

366.25-1.70 (-0.46%)

04:01 PM,18th Apr 2024

BSE : 543434

NSE : SUPRIYA

Sector : Health care

ISIN Code : INE07RO01027

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 18 2024 | 04:01 PM IST

Market Cap (₹ Cr)

2951

Turnover (₹ Cr)

0.43

Volume (Shares)

115983

Face Value

2

52-WK High

398.00

52-WK High Date

05 Apr 2024

52-WK Low

215.20

52-WK Low Date

05 May 2023

All Time High

601.90

All Time High Date

18 Jan 2022

All Time Low

170.15

All Time Low Date

27 Mar 2023

Supriya Lifescience Ltd

The company was incorporated as Supriya Lifescience Limited on 26 March 2008 upon the conversion of M/s Supriya Chemicalsa partnership firm into a public limited company.The company commenced operations on 01 April 2008.The company is engaged in manufacturing and export of active pharmaceutical ingredients(APIs).The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredientswith a focus on research and development. As of 31 March 2021the company have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine analgesic anaesthetic vitamin anti-asthmatic and antiallergic.The company have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India contributing to 45-55% and 65-70% respectivelyof the API exports from India between Fiscal 2017 and 2020.The company is among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume.The company's products are approved by various international regulatory authorities such as USFDA EUGMP EDQM SFDA NMPA ANVISA KFDA PMDA TGA and Taiwan FDA. As of 31 March 2021 the company have filed 11 active DMFs with USFDA and seven active CEPs with EDQM for API products in therapeutic areas such as antihistamine analgesic anaesthetic vitamin anti-asthmatic and anti-allergic.The company's business operations are supported by a modern manufacturing facility located in Parshuram Lote Maharashtra. The manufacturing facility is spread across 23806 sq.mts having reactor capacity of 332 KL per day.The company presently operate five cleanrooms and are setting up two new clean rooms that are expected to be commercialised in the first quarter of Fiscal 2022. The new clean rooms will add manufacturing capacity of 215 KL per day.On 31 March 2012the company has issued and allotted 3002400 equity shares of Rs 10 each as bonus shares to the shareholders in the ratio of 12:1.On 31 March 2013the company has issued and allotted 1626302 equity shares of Rs 10 each as bonus shares to the shareholders in the ratio of 1:2.On 01 October 2015the company has issued and allotted 9757804 equity shares of Rs 10 each as bonus shares to the shareholders in the ratio of 2:1On 26 December 2020the company has sub-divided its face value of equity shares from Rs 10 each to Rs 2 each.During the month of December 2021the company came out with an Rs 700-crore public issue which comprised of a fresh issue of Rs 200 crore and an offer for sale(OFS) of Rs 500 crore by the promoter Satish Waman Wagh.The IPO shares were allotted at the price of Rs 274 per share including a premium of Rs 272 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 28 December 2021.

Supriya Lifescience Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

2951

EPS - TTM (₹) [S]

14.96

P/E Ratio (X) [S]

3.92

Face Value (₹) 2
Latest Dividend (%)30.00
Latest Dividend Date 15 Sep 2023
Dividend Yield (%) 0.16
Book Value Share (₹) [S]93.58
P/B Ratio (₹) [S]3.92
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal Nifty Microcap 250 Index Fund-Reg (G) 1.28 38525 0.16
Motilal Oswal Nifty Microcap 250 Index Fund-Dir (G) 1.28 38525 0.16
Motilal Oswal S&P BSE Healthcare ETF 0.01 334 0.09
Groww Nifty Total Market Index Fund-Regular (G) 0.01 173 0.01
Groww Nifty Total Market Index Fund-Direct (G) 0.01 173 0.01

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

363.40

373.80

Week Low/High

352.55

384.00

Month Low/High

320.95

398.00

Year Low/High

215.20

398.00

All time Low/High

170.05

602.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-3.61%-3.66%-3.40-3.33%
1 Month12.23%12.06%-0.36-0.27%
3 Month22.15%22.09%1.832.49%
6 Month50.84%50.81%10.0411.82%
1 Year59.61%60.27%21.3724.55%
3 Year%%48.4550.47%

Company Info

Company Information

WTD & Additional Director : Manoj Deo Dorlikar

Registered Office: 207/208 Udyog Bhavan, Sonawala Road Goregaon (East),Mumbai,Maharashtra-400063 Ph: 91-22-40332727

Email:cs@supriyalifescience.com

URL:http://www.supriyalifescience.com